XML 19 R8.htm IDEA: XBRL DOCUMENT
v3.19.1

Note 3 - Selected Balance Sheet Data | 9 Months Ended
--- | ---
Mar. 31, 2019
Notes to Financial Statements |
Supplemental Balance Sheet Disclosures [Text Block] | Note 3 . Selected Balance Sheet Data: Inventories: Inventories consist of (in thousands):
|  | March 31, 201 9 |  |  | June 30, 2018 |
Raw materials |  | $ | 37,176 |  |  | $ | 30,956 |
Finished goods |  |  | 56,663 |  |  |  | 54,692 |
Inventories, net |  | $ | 93,839 |  |  | $ | 85,648 |
Property and Equipment: Property and equipment consist of (in thousands):
|  | March 31, |  |  | June 30, |
|  | 201 9 |  |  | 2018 |
Land |  | $ | 7,065 |  |  | $ | 7,065 |
Buildings and improvements |  |  | 172,826 |  |  |  | 170,110 |
Machinery and equipment |  |  | 117,105 |  |  |  | 107,625 |
Property and equipment, cost |  |  | 296,996 |  |  |  | 284,800 |
Accumulated depreciation and amortization |  |  | (151,677 | ) |  |  | (139,452 | )
Property and equipment, net |  | $ | 145,319 |  |  | $ | 145,348 |
Intangible Assets: Intangible assets consist of (in thousands):
|  | March 31, |  |  | June 30, |
|  | 201 9 |  |  | 2018 |
Developed technology |  | $ | 422,039 |  |  | $ | 305,303 |
Trade names |  |  | 147,340 |  |  |  | 89,608 |
Customer relationships |  |  | 212,996 |  |  |  | 212,228 |
Patents |  |  | 1,981 |  |  |  | 1,401 |
Intangible assets |  |  | 784,356 |  |  |  | 608,540 |
Accumulated amortization |  |  | (205,214 | ) |  |  | (162,208 | )
Intangible assets, net |  | $ | 579,142 |  |  | $ | 446,332 |
Changes to the carrying amount of net intangible assets for the nine months ended March 31, 2019 consist of (in thousands):
Beginning balance |  | $ | 446,332 |
Acquisitions |  |  | 177,500 |
Other additions |  |  | 558 |
Amortization expense |  |  | (43,797 | )
Currency translation |  |  | (1,451 | )
Ending balance |  | $ | 579,142 |
The estimated future amortization expense for intangible assets as of March 31, 2019 is as follows (in thousands):
2019 (remainder) |  | $ | 14,868 |
2020 |  |  | 58,873 |
2021 |  |  | 58,518 |
2022 |  |  | 56,822 |
2023 |  |  | 54,942 |
Thereafter |  |  | 335,119 |
Total |  | $ | 579,142 |
Goodwill: Changes to the carrying amount of goodwill for the nine months ended March 31, 2019 consist of (in thousands):
|  | Protein Sciences |  |  | Diagnostics and Genomics |  |  | Total |
Beginning balance |  | $ | 347,918 |  |  | $ | 249,972 |  |  | $ | 597,890 |
Acquisitions (Note 4) |  |  | 13,582 |  |  |  | 110,066 |  |  |  | 123,648 |
Currency translation |  |  | (1,821 | ) |  |  | (108 | ) |  |  | (1,930 | )
Ending balance |  | $ | 359,679 |  |  | $ | 359,929 |  |  | $ | 719,608 |
We evaluate the carrying value of goodwill in the fourth quarter of each fiscal year and between annual evaluations if events occur or circumstances change that would indicate a possible impairment. The Company performed a quantitative assessment for all of its reporting units during the fourth quarter of fiscal 2018. The quantitative assessment indicated that all of the reporting units had substantial headroom as of June 30, 2018. During the quarter ended March 31, 2019, the Company realigned the management of certain business processes between reporting units within the same reportable segment. A goodwill allocation was performed between the impacted reporting units based on the relative fair value of the processes realigned. In conjunction with the realignment, a quantitative goodwill impairment assessment was performed both prior to and subsequent to the realignment. The quantitative assessment indicated that all of the impacted reporting units had substantial headroom both prior to and subsequent to the realignment. No triggering events or items beyond the realignment that would require a goodwill impairment assessment were identified during the nine months ended March 31, 2019. There has been no impairment of goodwill since the adoption of Financial Accounting Standards Board (“FASB”) ASC 350 guidance for goodwill and other intangibles on July 1, 2002.

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -URI http://asc.fasb.org/topic&trid=2122208 + Details
Name: | us-gaap_SupplementalBalanceSheetDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration